<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01480752</url>
  </required_header>
  <id_info>
    <org_study_id>IRCT201108017191N1</org_study_id>
    <nct_id>NCT01480752</nct_id>
  </id_info>
  <brief_title>Reduction of Post-operative Endodontic Pain</brief_title>
  <official_title>the Effect of Intraligamentary Injection of Lornoxicam on the Intensity of Post-operative Endodontic Pain in the Tooth With Symptomatic Irreversible Pulpitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Islamic Azad University, Tehran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Islamic Azad University, Tehran</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the effect of intraligamentary injection of Lornoxicam on the intensity of
      post-operative endodontic pain in the tooth with symptomatic irreversible pulpitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      sixty qualified samples (initial estimate which will be come more accurate after the pilot
      study on 6 patients) will be divided randomly in three groups which all of them will have an
      inferior Alveolar injection and before the beginning of the treatment the primary group will
      receive an injection of 0.4 mL ( 0.2 mL in mesio buccal and 0.2 mL in disto buccal) of
      Lornoxicam and the second group will be injected with 0.4 mL of normal saline( 0.2 mL in
      mesio buccal and 0.2 mL in disto buccal) ,in third group we will only pretend the injection
      but actually there is no substance injected ,making the patient believe that there was an
      injection . Then the patients' pain will be evaluated with visual Analogue Scale analysis
      (VAS) 0-170 mm in time intervals of 6, 12, 24 and 48 hours after the treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post operative endodontic's pain</measure>
    <time_frame>6,12,24,48 hours after drug's injection</time_frame>
    <description>The measuring method of the pain is VAS(Visual Analogue Scale).</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Post Operative Endodontic Pain</condition>
  <arm_group>
    <arm_group_label>Lornoxicam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>no injection</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lornoxicam</intervention_name>
    <description>PDL injection of 0/2 ml of lornoxicam (4mg/ml),before the root therapy and after the inferior alveolar injection</description>
    <arm_group_label>Lornoxicam</arm_group_label>
    <other_name>Xefo</other_name>
    <other_name>(904111)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>PDl injection of 0/2 ml normal saline before the root therapy and after inferior alveolar injection</description>
    <arm_group_label>normal saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>no injection</intervention_name>
    <description>inject nothing after inferior alveolar injection and before root canal therapy</description>
    <arm_group_label>no injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy (ASA I, II);

          -  Patients with first or second mandibular molars who need endodontic treatment;

          -  Vital tooth without a history of past endodontic treatment;

          -  Patients with clinical evidence of irreversible Pulpits with moderate to severe pain;

          -  Patients without pre apical lesion and periodontal ligament enlargement more than
             0.75-1mm on the x-ray images;

          -  Patients in the age group of 18-65 years old

        Exclusion Criteria:

          -  Pregnant or nursing;

          -  necrotic tooth;

          -  Patients with allergy or contraindication toward non-opioid or opioid painkillers such
             as aspirin or NSAIDs;

          -  People who have a history of acute peptic ulcer, during the past 12 months;

          -  People who have bleeding problems or have been taking anticoagulant drugs over the
             past month;

          -  Patients who have taken opioid or non opioid or steroid pain killers, antidepressants
             or sedative drugs.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Dental School of Azad University</name>
      <address>
        <city>Tehran</city>
        <zip>1946853314</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2011</study_first_submitted>
  <study_first_submitted_qc>November 24, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2011</study_first_posted>
  <last_update_submitted>January 11, 2013</last_update_submitted>
  <last_update_submitted_qc>January 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Islamic Azad University, Tehran</investigator_affiliation>
    <investigator_full_name>Mandana Abedi Tari</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <keyword>In the patients with symptomatic Irreversible Pulpitis</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lornoxicam</mesh_term>
    <mesh_term>Piroxicam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

